Jefferies Financial Group’s Cabaletta Bio CABA Stock Holding History

Jefferies Financial Group’s Portfolio CABA Stock Details CABA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$90K	Sell	33,442 -11,683	-26%	-$32.4K	﹤0.01%	1609
2025 Q4	$98.8K	Sell	45,125 -2,375	-5%	-$5.88K	﹤0.01%	1703
2025 Q3	$111K	Sell	47,500 -1,949,708	-98%	-$3.35M	﹤0.01%	1329
2025 Q2	$3.04M	Buy	+1,997,208	New	+$3.11M	0.03%	426
2023 Q1	–	Sell	-25,000	Closed	-$231K	–	1654
2022 Q4	$231K	Buy	+25,000	New	+$91K	﹤0.01%	1262

Other funds holding CABA

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Jefferies Financial Group's CABA Position: Q1 2026 in Review

Jefferies Financial Group reduced its Cabaletta Bio (CABA) stake by 26% in Q1 2026, selling an estimated $32.4K and leaving 33,442 shares worth $90K. The position accounts for ﹤0.01% of the portfolio, ranked #1609.

Jefferies Financial Group first reported a position in CABA in Q4 2022 and has held it in 5 quarters since. The position peaked at $3.04M in Q2 2025. 108 funds tracked by Wall St. Rank hold CABA as of Q1 2026.

Jefferies Financial Group held 33,442 shares of Cabaletta Bio worth $90K as of Q1 2026.
Jefferies Financial Group sold 11,683 Cabaletta Bio shares in Q1 2026, an estimated $32.4K.
Cabaletta Bio made up ﹤0.01% of Jefferies Financial Group's portfolio in Q1 2026, its #1609 holding.
Jefferies Financial Group first reported a position in Cabaletta Bio in Q4 2022 and has held it in 5 quarters since.
Jefferies Financial Group's Cabaletta Bio position peaked at $3.04M in Q2 2025.
108 funds tracked by Wall St. Rank held Cabaletta Bio as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.